Comparative impact of implementing the 2013 or 2014 cholesterol guideline on vascular events in a quality improvement network

Conclusions:
The 2013 guideline is projected to prevent more clinical ASCVD events and with lower NNTs than the 2014 guideline, yet both have substantial benefit. The 2013 guideline is also expected to generate more adverse events, but the risk-benefit profile appears favor .

Source: Therapeutic Advances in Cardiovascular Disease - April 6, 2016 Category: Cardiology Authors: Egan, B. M., Sutherland, S. E., Childers, W. F., Dahlheimer, R. M., Helmrich, G. A., Lapeyrolerie, D. A., Markle, N., Murphy, D. W., Simmons, L., Davis, R. A., Tilkemeier, P., Sinopoli, A. Tags: Original Research Source Type: research